These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 14988745)

  • 21. Immunotherapy for metastatic renal cell carcinoma.
    Wirth MP
    Urol Clin North Am; 1993 May; 20(2):283-95. PubMed ID: 7684167
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel treatment strategies in clear-cell metastatic renal cell carcinoma.
    van Spronsen DJ; de Weijer KJ; Mulders PF; De Mulder PH
    Anticancer Drugs; 2005 Aug; 16(7):709-17. PubMed ID: 16027518
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunomodulatory Therapies for Renal Cell Carcinoma.
    Liu M; Wu H; Shangguan D; Jiang Y; Li X; Liu S; Zhou B; Yin T; Gong Z
    Protein Pept Lett; 2018; 25(6):534-547. PubMed ID: 29848257
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeted therapy for renal cell carcinoma: a new therapeutic paradigm.
    Shaheen PE; Bukowski RM
    Cancer Invest; 2006 Oct; 24(6):640-56. PubMed ID: 16982470
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel investigative approaches for advanced renal cell carcinoma.
    Berg WJ; Divgi CR; Nanus DM; Motzer RJ
    Semin Oncol; 2000 Apr; 27(2):234-9. PubMed ID: 10768602
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeted therapy for metastatic renal cell cancer.
    Verbaeys C; Hoebeke P; Van Belle S; Rottey S
    Acta Clin Belg; 2010; 65(2):115-21. PubMed ID: 20491361
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Immunology in clinical practice. XVII. Immunotherapy of metastatic renal cell carcinoma. Work Group Immunotherapy, Dutch Oncology].
    van Herpen CM; de Mulder PH
    Ned Tijdschr Geneeskd; 1998 Nov; 142(48):2613-8. PubMed ID: 10028361
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rationale for immunotherapy of renal cell carcinoma.
    Heicappell R; Ackermann R
    Urol Res; 1990; 18(6):357-72. PubMed ID: 2100410
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sarcomatoid renal cell carcinoma: biologic behavior, prognosis, and response to combined surgical resection and immunotherapy.
    Cangiano T; Liao J; Naitoh J; Dorey F; Figlin R; Belldegrun A
    J Clin Oncol; 1999 Feb; 17(2):523-8. PubMed ID: 10080595
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Cytokine therapy of metastatic renal cell carcinoma].
    Otto T; Goepel M; Luboldt HJ; Rübben H
    Urologe A; 1995 May; 34(3):200-3. PubMed ID: 7610512
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New treatments for metastatic kidney cancer.
    Mancuso A; Sternberg CN
    Can J Urol; 2005 Feb; 12 Suppl 1():66-70; discussion 105. PubMed ID: 15780170
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment selection for patients with metastatic renal cell carcinoma: identification of features favoring upfront IL-2-based immunotherapy.
    Atkins MB
    Med Oncol; 2009; 26 Suppl 1():18-22. PubMed ID: 19165638
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ten-year survival results in metastatic renal cell cancer patients treated with monoimmunotherapy with subcutaneous low-dose interleukin-2.
    Lissoni P; Bordin V; Vaghi M; Fumagalli L; Bordoni A; Mengo S; Bucovec R; Fumagalli E; Malugani F; Ardizzoia A; Giani L; Gardani GS; Tancini G
    Anticancer Res; 2002; 22(2B):1061-4. PubMed ID: 12168901
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Emerging therapeutics in refractory renal cell carcinoma.
    Koshkin VS; Rini BI
    Expert Opin Pharmacother; 2016 Jun; 17(9):1225-32. PubMed ID: 27112171
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A survey of therapy for advanced renal cell carcinoma.
    Basso M; Cassano A; Barone C
    Urol Oncol; 2010; 28(2):121-33. PubMed ID: 19576800
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nonablative hematopoietic cell transplantation for the treatment of metastatic renal cell carcinoma.
    Nelson RP; Logan TF; Abonour R
    Bone Marrow Transplant; 2002 Dec; 30(12):805-12. PubMed ID: 12476272
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeted therapies in metastatic renal cell carcinoma: the light at the end of the tunnel.
    Pouessel D; Culine S
    Expert Rev Anticancer Ther; 2006 Dec; 6(12):1761-7. PubMed ID: 17181490
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Immunotherapy of renal cell carcinoma: results from current phase-III-trials].
    Doehn C; Jocham D
    Aktuelle Urol; 2004 Apr; 35(2):121-9. PubMed ID: 15146376
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytokine therapy: a standard of care for metastatic renal cell carcinoma?
    Hutson TE; Quinn DI
    Clin Genitourin Cancer; 2005 Dec; 4(3):181-6. PubMed ID: 16425986
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combination or sequencing strategies to improve the outcome of metastatic renal cell carcinoma patients: a critical review.
    Porta C; Szczylik C; Escudier B
    Crit Rev Oncol Hematol; 2012 Jun; 82(3):323-37. PubMed ID: 21733715
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.